Renaissance Technologies’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-131,100
| Closed | -$2.64M | – | 4359 |
|
|
2021
Q3 | $2.64M | Sell |
131,100
-100
| -0.1% | -$2.76K | ﹤0.01% | 1882 |
|
|
2021
Q2 | $4.9M | Sell |
131,200
-16,445
| -11% | -$504K | 0.01% | 1649 |
|
|
2021
Q1 | $3.77M | Sell |
147,645
-539,233
| -79% | -$13.8M | ﹤0.01% | 1825 |
|
|
2020
Q4 | $15.1M | Sell |
686,878
-461,022
| -40% | -$10.2M | 0.02% | 905 |
|
|
2020
Q3 | $20.7M | Buy |
1,147,900
+237,700
| +26% | +$4.92M | 0.02% | 722 |
|
|
2020
Q2 | $23.1M | Buy |
910,200
+151,100
| +20% | +$3.26M | 0.02% | 739 |
|
|
2020
Q1 | $13.9M | Sell |
759,100
-233,300
| -24% | -$4.53M | 0.01% | 961 |
|
|
2019
Q4 | $21.9M | Buy |
992,400
+507,000
| +104% | +$10.2M | 0.02% | 954 |
|
|
2019
Q3 | $6.97M | Buy |
+485,400
| New | +$6.94M | 0.01% | 1618 |
|
|
2018
Q3 | – | Sell |
-71,100
| Closed | -$871K | – | 3644 |
|
|
2018
Q2 | $871K | Sell |
71,100
-218,300
| -75% | -$2.74M | ﹤0.01% | 2652 |
|
|
2018
Q1 | $2.77M | Sell |
289,400
-270,900
| -48% | -$2.92M | ﹤0.01% | 2156 |
|
|
2017
Q4 | $5.06M | Buy |
560,300
+90,700
| +19% | +$667K | 0.01% | 1796 |
|
|
2017
Q3 | $2.7M | Buy |
469,600
+26,500
| +6% | +$96.4K | ﹤0.01% | 2129 |
|
|
2017
Q2 | $1.41M | Buy |
443,100
+24,600
| +6% | +$77.7K | ﹤0.01% | 2436 |
|
|
2017
Q1 | $1.42M | Buy |
418,500
+9,818
| +2% | +$27.6K | ﹤0.01% | 2410 |
|
|
2016
Q4 | $1.18M | Buy |
408,682
+84,682
| +26% | +$301K | ﹤0.01% | 2481 |
|
|
2016
Q3 | $1.91M | Buy |
324,000
+248,400
| +329% | +$871K | ﹤0.01% | 2217 |
|
|
2016
Q2 | $227K | Buy |
75,600
+45,700
| +153% | +$188K | ﹤0.01% | 3013 |
|
|
2016
Q1 | $160K | Buy |
+29,900
| New | +$189K | ﹤0.01% | 3145 |
|
|
2015
Q3 | – | Sell |
-61,700
| Closed | -$861K | – | 3443 |
|
|
2015
Q2 | $861K | Buy |
61,700
+49,100
| +390% | +$901K | ﹤0.01% | 2526 |
|
|
2015
Q1 | $303K | Buy |
+12,600
| New | +$283K | ﹤0.01% | 2764 |
|
Other funds holding DRNA
Renaissance Technologies's DRNA Position: Q4 2021 in Review
Renaissance Technologies sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 131,100 shares — an estimated $2.64M sold.
Renaissance Technologies first reported a position in DRNA in Q1 2015 and held it in 21 quarters. The position peaked at $23.1M in Q2 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Renaissance Technologies reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Renaissance Technologies sold 131,100 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2.64M.
- Renaissance Technologies first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2015 and held it in 21 quarters.
- Renaissance Technologies's Dicerna Pharmaceuticals, Inc. position peaked at $23.1M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Renaissance Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.